JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Tseng, G.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Tseng, G.-N.

Vol. 287, Issue 1, 332-343, October 1998

Differential Effects of S6 Mutations on Binding of Quinidine and 4-Aminopyridine to Rat Isoform of Kv1.4: Common Site but Different Factors in Determining Blockers' Binding Affinity1

Hailing Zhang, Bing Zhu, Jian-An Yao and Gea-Ny Tseng

Department of Pharmacology, Columbia University, New York, New York

Quinidine and 4AP are two nonspecific K channel blockers. Both block voltage-gated K channels from the intracellular side of the membrane and, in most cases, binding is facilitated by channel activation. However, there are distinct differences between quinidine and 4AP in the time- and voltage-dependencies of drug-channel interaction. To learn about the molecular basis underlying the similarities as well as differences in drug actions between quinidine and 4AP, we used rKv1.4 (rat isoform of Kv1.4) as a model and studied: 1) Is there an overlap between the binding sites of quinidine and 4AP? and 2) What factors are involved in determining the binding affinity and kinetics of drug-channel interaction? Our data show that mutations at a position in the S6 domain of rKv1.4 (position 529) can cause dramatic and often opposite effects on quinidine and 4AP binding. For quinidine, the degree of steric hindrance imposed by side chain at position 529 is an important factor in determining binding affinity. For 4AP, 529 mutations that slow the rate of deactivation reduce binding affinity, probably due to a low binding affinity in the open state. This, in conjunction with the observations that 4AP binding is facilitated by channel activation, suggests that optimal 4AP binding may occur in a transitional state between fully-closed and fully-open states. In addition, hydrophobic interactions between blocker molecules and residues at 529 tend to stabilize the binding of both quinidine and 4AP. Because the S6 amino acid sequences are well conserved among many voltage-gated K channels, our findings have general implications in understanding the structural determinants of quinidine and 4AP binding to different K channels.

0022-3565/98/2871-0332$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
X. Xu, M. Recanatini, M. Roberti, and G.-N. Tseng
Probing the Binding Sites and Mechanisms of Action of Two Human Ether-a-go-go-Related Gene Channel Activators, 1,3-bis-(2-Hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)
Mol. Pharmacol., June 1, 2008; 73(6): 1709 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Herrera, A. Mamarbachi, M. Simoes, L. Parent, R. Sauve, Z. Wang, and S. Nattel
A Single Residue in the S6 Transmembrane Domain Governs the Differential Flecainide Sensitivity of Voltage-Gated Potassium Channels
Mol. Pharmacol., August 1, 2005; 68(2): 305 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Sanchez-Chapula, T. Ferrer, R. A. Navarro-Polanco, and M. C. Sanguinetti
Voltage-Dependent Profile of Human Ether-a-go-go-Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain
Mol. Pharmacol., May 1, 2003; 63(5): 1051 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
I. Moreno, R. Caballero, T. Gonzalez, C. Arias, C. Valenzuela, I. Iriepa, E. Galvez, J. Tamargo, and E. Delpon
Effects of Irbesartan on Cloned Potassium Channels Involved in Human Cardiac Repolarization
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 862 - 873.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
S. Wang, M. J Morales, Y.-J. Qu, G. C L Bett, H. C Strauss, and R. L Rasmusson
Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect
J. Physiol., January 15, 2003; 546(2): 387 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. P. Lees-Miller, Y. Duan, G. Q. Teng, and H. J. Duff
Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites
Mol. Pharmacol., February 1, 2000; 57(2): 367 - 374.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
G.-N. Tseng
Different State Dependencies of 4-Aminopyridine Binding to rKv1.4 and rKv4.2: Role of the Cytoplasmic Halves of the Fifth and Sixth Transmembrane Segments
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 569 - 577.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.